Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.
About SocialNewsXYZ
An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.
Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.